Developer docs
API playgroundTry for free, no card

Search company profiles

Synetic Life Sciences

Full company profile

uuid003ejgi

Namestring
Synetic Life Sciences
Legal namestring
Lucid Group
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Synetic Life Sciences is positioned in the source material as a specialist management consulting firm dedicated to the life sciences sector, headquartered in London, United Kingdom. Its stated operating model is to serve pharmaceutical, biotechnology, and medtech clients through a portfolio of five integrated capabilities: Strategy Consulting (asset strategy, business design and transformation, and patient and customer value), Scientific and Medical Communications, Commercial Communications, Lucid Connected Intelligence (a data and analytics offering), and AI-Powered Solutions (covering AI strategy, governance, use case definition, and adoption). The firm's go-to-market is sales-led and enterprise-focused, engaging directly with pharmaceutical executives and leadership teams on multi-year, project-based engagements with custom pricing.

The firm's underlying technology layer is described as comprising consulting services "enabled by AI and advanced analytics capabilities," with Lucid Connected Intelligence positioned as the connective platform that integrates analytics across the service portfolio and AI-Powered Solutions handling AI strategy, governance, use case definition, and build/adoption work. Proprietary content assets include an extensive library of case studies (covering pipeline prioritization, global evidence generation, medical affairs operating model design, portfolio buy-and-build, and patient support program launches) and published white papers on Decentralised Clinical Trials, Medical Operations of the Future, and Medical Affairs KPIs.

The firm competes against generalist management consultancies by emphasizing exclusive life sciences focus, senior experienced consultants, and what it characterizes as being "big enough but not too big." Its revenue model is professional services fees on custom engagement-based pricing, with multi-year contract cadences implied. The source material contains no disclosed revenue, no named customer logos, no headcount figures, and no funding history. The firmographic record lists founding year 2020, while the operating company's own materials claim "over 20 years" of brand reputation — a discrepancy the source does not resolve. No partnerships, acquisitions, regulatory actions, or leadership team disclosures beyond a single US Vice President are present in the input data.

Short descriptiontext

Synetic Life Sciences is a London-based specialist consulting firm dedicated to life sciences, offering strategy consulting, medical and commercial communications, connected intelligence, and AI-powered solutions to pharmaceutical, biotech, and medtech clients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
life sciences consulting, pharmaceutical strategy consulting, biopharma advisory services, medical affairs consulting, healthcare management consulting
Industry3 codes
PRIMARYBPAHACAA
Strategy & Corporate Development Consulting
SECONDARYBPAHACAM
Innovation, Product & R&D Consulting
SECONDARYHLAGAOAG
Medical Affairs, Scientific Communications & HEOR FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code2 codes
  • Management Consulting Services54161
  • Other Scientific and Technical Consulting Services54169
SIC code2 codes
  • Services-Management Consulting Services8742
  • Services-Engineering, Accounting, Research, Management8700
Product category
Life Sciences Consulting
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Strategy Consulting Services
TypeProfessional Services
Description

Management consulting engagements providing expertise-led and outcome-driven support for pharmaceutical companies across asset strategy, business transformation, and customer value initiatives. Projects include market evaluation, launch excellence planning, operating model design, and digital transformation programs.

wearelucidgroup.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Custom engagement-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Consulting engagements are tailored to client needs with pricing based on scope, complexity, and project duration.

wearelucidgroup.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1Lucid Strategy Consulting
Description

The strategic management consulting arm of Lucid Group, offering expertise in asset strategy, business design & transformation, and patient & customer value for life sciences companies.

wearelucidgroup.com
+2 more records
Core offering1 text field

Synetic Life Sciences is a specialist consulting firm focused on the life sciences, providing strategic management consulting and advisory services to biopharma companies, providers and investors. The firm delivers five integrated capabilities: Strategy Consulting (asset strategy, business design and transformation, and patient and customer value), Scientific and Medical Communications, Commercial Communications, Lucid Connected Intelligence (data and analytics), and AI-Powered Solutions for pharma transformation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Accelerated time-to-approval for pharma assets
+2 more records
Product overview1 text field

Lucid Group is a strategic management consulting firm dedicated to life sciences, offering a platform of consulting services that help pharma leaders unlock asset potential, transform functions across development and commercial operations, and create value for customers and patients. The portfolio consists of five integrated capabilities: Strategy Consulting (core offering covering asset strategy, business design and transformation, and patient/customer value), Scientific and Medical Communications, Commercial Communications, Lucid Connected Intelligence (data and analytics), and AI-Powered Solutions (AI strategy and adoption). These capabilities work together to drive transformation enabled by AI and advanced analytics.

Product and service5 records
1Strategy Consulting
CategoryStrategy Consulting
Description

Strategic management consulting dedicated to life sciences, helping pharma clients with asset strategy, business design and transformation, and patient and customer value delivery across market, asset and portfolio evaluation, launch excellence, and lifecycle planning.

2Scientific and Medical Communications
CategoryMedical Communications
Description

Medical communications services supporting pharma companies in engaging with healthcare professionals and stakeholders, delivered under the firm's capabilities portfolio.

3Commercial Communications
CategoryCommercial Communications
Description

Commercial communications services helping pharma companies adapt go-to-market strategies and operating models through consulting engagement.

4Lucid Connected Intelligence
CategoryData and Analytics
Description

Data and analytics capability enabling pharma companies to leverage connected intelligence across their operations, integrated with the firm's consulting capabilities.

5AI-Powered Solutions
CategoryAI Strategy and Transformation
Description

AI-enabled consulting solutions incorporating AI strategy, governance, use case definition, build and adoption to support pharma transformation across Medical Affairs and commercial operations.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Syneos Health combines commercial consulting with contract sales and clinical solutions for pharma/biotech, competing on commercial transformation and launch excellence engagements at larger scale than specialist consultancies.

TypeBroad incumbent
Description

IQVIA is the largest life sciences technology and analytics provider, combining data, RWD, and consulting services for pharma. It competes with the firm on strategy and Medical Affairs transformation engagements, though at vastly greater scale and with proprietary data assets.

TypeBroad incumbent
Description

BCG's Healthcare practice serves global pharma and biotech on strategy, launch, and operating model transformation, frequently partnering with biopharma leadership teams on multi-year engagements similar in scope to the firm's Business Design & Transformation work.

TypeDirect peer
Description

L.E.K. is a global strategy consulting firm with a sizable dedicated life sciences practice covering pharma, biotech, and medtech strategy. It competes directly on asset strategy, launch excellence, and commercial transformation mandates.

TypeDirect peer
Description

Trinity Life Sciences is a life sciences-focused commercial strategy and insights firm serving pharma and biotech with evidence generation, brand strategy, and launch planning — closely aligned to the firm's Patient & Customer Value and Asset Strategy capabilities.

6ZS Associates
TypeDirect peer
Description

ZS Associates is a global consulting firm exclusively dedicated to life sciences and healthcare, with deep expertise in pharma strategy, sales/marketing, and AI/analytics — a directly comparable specialist competitor with a similar domain-only positioning and analytics-embedded services.

TypeDirect peer
Description

ClearView is a boutique life sciences strategy firm focused on biopharma asset strategy, commercial planning, and market access. It is a close peer on specialty pharma and biotech mandates.

TypeDirect peer
Description

CRA's Life Sciences practice provides strategy and economic consulting to pharma and biotech, including portfolio strategy, pricing, and evidence generation — directly comparable to the firm's Asset Strategy and Business Transformation offerings.

TypeBroad incumbent
Description

McKinsey's Pharmaceuticals & Medical Products practice covers the full lifecycle from R&D strategy through commercial transformation, often with global transformation programs. It is the dominant generalist incumbent competing for the same enterprise-level pharma mandates.

TypeDirect peer
Description

Putnam is a specialized strategy consulting firm serving biopharma and MedTech, with deep expertise in asset and portfolio strategy, launch planning, and commercial model design — directly comparable to the firm's core asset strategy offerings.

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Synetic Life Sciences

Life Sciences Consultingsyneticlifesciences.com

Synetic Life Sciences is a London-based specialist consulting firm dedicated to life sciences, offering strategy consulting, medical and commercial communications, connected intelligence, and AI-powered solutions to pharmaceutical, biotech, and medtech clients.

What Synetic Life Sciences does

Synetic Life Sciences is positioned in the source material as a specialist management consulting firm dedicated to the life sciences sector, headquartered in London, United Kingdom. Its stated operating model is to serve pharmaceutical, biotechnology, and medtech clients through a portfolio of five integrated capabilities: Strategy Consulting (asset strategy, business design and transformation, and patient and customer value), Scientific and Medical Communications, Commercial Communications, Lucid Connected Intelligence (a data and analytics offering), and AI-Powered Solutions (covering AI strategy, governance, use case definition, and adoption). The firm's go-to-market is sales-led and enterprise-focused, engaging directly with pharmaceutical executives and leadership teams on multi-year, project-based engagements with custom pricing.

The firm's underlying technology layer is described as comprising consulting services "enabled by AI and advanced analytics capabilities," with Lucid Connected Intelligence positioned as the connective platform that integrates analytics across the service portfolio and AI-Powered Solutions handling AI strategy, governance, use case definition, and build/adoption work. Proprietary content assets include an extensive library of case studies (covering pipeline prioritization, global evidence generation, medical affairs operating model design, portfolio buy-and-build, and patient support program launches) and published white papers on Decentralised Clinical Trials, Medical Operations of the Future, and Medical Affairs KPIs.

The firm competes against generalist management consultancies by emphasizing exclusive life sciences focus, senior experienced consultants, and what it characterizes as being "big enough but not too big." Its revenue model is professional services fees on custom engagement-based pricing, with multi-year contract cadences implied. The source material contains no disclosed revenue, no named customer logos, no headcount figures, and no funding history. The firmographic record lists founding year 2020, while the operating company's own materials claim "over 20 years" of brand reputation — a discrepancy the source does not resolve. No partnerships, acquisitions, regulatory actions, or leadership team disclosures beyond a single US Vice President are present in the input data.

Synetic Life Sciences firmographics

Firmographics
Name
Synetic Life Sciences
Legal name
Lucid Group
Website
https://syneticlifesciences.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
Synetic Life Sciences is a London-based specialist consulting firm dedicated to life sciences, offering strategy consulting, medical and commercial communications, connected intelligence, and AI-powered solutions to pharmaceutical, biotech, and medtech clients.
Ownership category
akta.pro rank

Synetic Life Sciences industry classification

Industry
Product category
Life Sciences Consulting
NAICS
Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Management Consulting Services (8742), Services-Engineering, Accounting, Research, Management (8700)
akta.pro industry
PRIMARYBPAHACAA
Strategy & Corporate Development Consulting
SECONDARYBPAHACAM
Innovation, Product & R&D Consulting
SECONDARYHLAGAOAG
Medical Affairs, Scientific Communications & HEOR FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Life sciences consulting
  • Pharmaceutical strategy consulting
  • Biopharma advisory services
  • Medical affairs consulting
  • Healthcare management consulting

Where Synetic Life Sciences is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Markets served

Synetic Life Sciences business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Strategy Consulting Services: Management consulting engagements providing expertise-led and outcome-driven support for pharmaceutical companies across asset strategy, business transformation, and customer value initiatives. Projects include market evaluation, launch excellence planning, operating model design, and digital transformation programs.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom engagement-based pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Synetic Life Sciences product offering

Product offering

Core offering

Synetic Life Sciences is a specialist consulting firm focused on the life sciences, providing strategic management consulting and advisory services to biopharma companies, providers and investors. The firm delivers five integrated capabilities: Strategy Consulting (asset strategy, business design and transformation, and patient and customer value), Scientific and Medical Communications, Commercial Communications, Lucid Connected Intelligence (data and analytics), and AI-Powered Solutions for pharma transformation.

Product overview

Lucid Group is a strategic management consulting firm dedicated to life sciences, offering a platform of consulting services that help pharma leaders unlock asset potential, transform functions across development and commercial operations, and create value for customers and patients. The portfolio consists of five integrated capabilities: Strategy Consulting (core offering covering asset strategy, business design and transformation, and patient/customer value), Scientific and Medical Communications, Commercial Communications, Lucid Connected Intelligence (data and analytics), and AI-Powered Solutions (AI strategy and adoption). These capabilities work together to drive transformation enabled by AI and advanced analytics.

Differentiator

Problem solved

Functional benefit

Brands

  • Lucid Strategy Consulting: The strategic management consulting arm of Lucid Group, offering expertise in asset strategy, business design & transformation, and patient & customer value for life sciences companies.
  • Lucid Connected Intelligence
  • AI-Powered Solutions

Products and services

  • Strategy Consulting Strategic management consulting dedicated to life sciences, helping pharma clients with asset strategy, business design and transformation, and patient and customer value delivery across market, asset and portfolio evaluation, launch excellence, and lifecycle planning.
  • Scientific and Medical Communications Medical communications services supporting pharma companies in engaging with healthcare professionals and stakeholders, delivered under the firm's capabilities portfolio.
  • Commercial Communications Commercial communications services helping pharma companies adapt go-to-market strategies and operating models through consulting engagement.
  • Lucid Connected Intelligence Data and analytics capability enabling pharma companies to leverage connected intelligence across their operations, integrated with the firm's consulting capabilities.
  • AI-Powered Solutions AI-enabled consulting solutions incorporating AI strategy, governance, use case definition, build and adoption to support pharma transformation across Medical Affairs and commercial operations.

Quantifiable outcome

  • Accelerated time-to-approval for pharma assets
  • +2 more outcomes

Companies that use Synetic Life Sciences

Customer profile

Segments4 records

Ideal customer profiles4 records

Synetic Life Sciences technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Synetic Life Sciences partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves4 records

Expansion highlights5 records

Synetic Life Sciences competitors and assessment

Company assessment

Broad incumbents

  • Syneos Health Consulting: Syneos Health combines commercial consulting with contract sales and clinical solutions for pharma/biotech, competing on commercial transformation and launch excellence engagements at larger scale than specialist consultancies.
  • IQVIA: IQVIA is the largest life sciences technology and analytics provider, combining data, RWD, and consulting services for pharma. It competes with the firm on strategy and Medical Affairs transformation engagements, though at vastly greater scale and with proprietary data assets.
  • Boston Consulting Group (Healthcare): BCG's Healthcare practice serves global pharma and biotech on strategy, launch, and operating model transformation, frequently partnering with biopharma leadership teams on multi-year engagements similar in scope to the firm's Business Design & Transformation work.
  • McKinsey & Company (Pharma Practice): McKinsey's Pharmaceuticals & Medical Products practice covers the full lifecycle from R&D strategy through commercial transformation, often with global transformation programs. It is the dominant generalist incumbent competing for the same enterprise-level pharma mandates.

Direct peers

  • L.E.K. Consulting: L.E.K. is a global strategy consulting firm with a sizable dedicated life sciences practice covering pharma, biotech, and medtech strategy. It competes directly on asset strategy, launch excellence, and commercial transformation mandates.
  • Trinity Life Sciences: Trinity Life Sciences is a life sciences-focused commercial strategy and insights firm serving pharma and biotech with evidence generation, brand strategy, and launch planning — closely aligned to the firm's Patient & Customer Value and Asset Strategy capabilities.
  • ZS Associates: ZS Associates is a global consulting firm exclusively dedicated to life sciences and healthcare, with deep expertise in pharma strategy, sales/marketing, and AI/analytics — a directly comparable specialist competitor with a similar domain-only positioning and analytics-embedded services.
  • ClearView Healthcare Partners: ClearView is a boutique life sciences strategy firm focused on biopharma asset strategy, commercial planning, and market access. It is a close peer on specialty pharma and biotech mandates.
  • Charles River Associates: CRA's Life Sciences practice provides strategy and economic consulting to pharma and biotech, including portfolio strategy, pricing, and evidence generation — directly comparable to the firm's Asset Strategy and Business Transformation offerings.
  • Putnam Associates: Putnam is a specialized strategy consulting firm serving biopharma and MedTech, with deep expertise in asset and portfolio strategy, launch planning, and commercial model design — directly comparable to the firm's core asset strategy offerings.

Market position

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Synetic Life Sciences social profiles

Digital presence

Synetic Life Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Synetic Life Sciences leadership team

Management profile

Number of profiles

Profiles1 record

Synetic Life Sciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Synetic Life Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synetic Life Sciences

What does Synetic Life Sciences do?

Synetic Life Sciences is a specialist consulting firm focused on the life sciences, providing strategic management consulting and advisory services to biopharma companies, providers and investors. The firm delivers five integrated capabilities: Strategy Consulting (asset strategy, business design and transformation, and patient and customer value), Scientific and Medical Communications, Commercial Communications, Lucid Connected Intelligence (data and analytics), and AI-Powered Solutions for pharma transformation.

Is Synetic Life Sciences a public or private company?

Synetic Life Sciences is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Synetic Life Sciences founded?

Synetic Life Sciences was founded in 2020. It employs 1 to 10 people.

Where is Synetic Life Sciences based?

Synetic Life Sciences is headquartered in London, United Kingdom, in the Europe region.

How does Synetic Life Sciences make money?

One revenue line is on record: strategy Consulting Services.

Who are Synetic Life Sciences's main competitors?

Broad incumbents on record are Syneos Health Consulting, IQVIA, Boston Consulting Group (Healthcare) and McKinsey & Company (Pharma Practice). Direct peers are L.E.K. Consulting, Trinity Life Sciences, ZS Associates, ClearView Healthcare Partners, Charles River Associates and Putnam Associates.

Does Synetic Life Sciences have an API?

No public API is recorded for Synetic Life Sciences.

What industry is Synetic Life Sciences in?

Synetic Life Sciences's product category is Life Sciences Consulting. Its primary akta.pro industry code is BPAHACAA, Strategy & Corporate Development Consulting, with a secondary code of BPAHACAM, Innovation, Product & R&D Consulting. Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales